13D/13G Filings - Verve Therapeutics Inc. (VERV)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-24
08:22 am
Purchase
2022-01-1313GVerve Therapeutics, Inc.
VERV
SINGER JAMES R2,465,000
5.100%
2,465,000increase
(New Position)
Filing
History
2021-12-28
12:05 pm
Purchase
2021-12-2813GVerve Therapeutics, Inc.
VERV
FMR LLC4,841,725
10.051%
1,522,263increase
(+45.86%)
Filing
History
2021-06-28
08:50 am
Purchase
2021-06-1713GVerve Therapeutics, Inc.
VERV
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.2,495,571
5.180%
2,495,571increase
(New Position)
Filing
History
2021-06-23
11:38 am
Purchase
2021-06-1713GVerve Therapeutics, Inc.
VERV
Casdin Capital LLC3,038,167
6.600%
3,038,167increase
(New Position)
Filing
History
2021-06-23
11:08 am
Purchase
2021-06-2213GVerve Therapeutics, Inc.
VERV
FMR LLC3,319,462
7.198%
3,319,462increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2